vimarsana.com

Latest Breaking News On - Sumanta kumar pal - Page 1 : vimarsana.com

DFF332 Elicits Efficacy and Is Safe in Advanced Clear Cell RCC

The small molecule inhibitor DFF332 elicited clinical activity and had a tolerable safety profile in patients with advanced clear cell renal cell carcinoma.

Revisit Every OncLive On Air Episode From May 2024

Revisit Every OncLive On Air Episode From May 2024
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Dr Pal Previews ASCO 2024 Data in Renal Cell Carcinoma

Sumanta Kumar Pal, MD, FASCO, discusses key biomarker analyses in renal cell carcinoma that will be presented at the 2024 ASCO Annual Meeting.

City of Hope to Unveil New Cancer Treatments at 2024 ASCO Meeting

City of Hope to Unveil New Cancer Treatments at 2024 ASCO Meeting
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.